Meet the OBR Editorial Board

Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.

View all Editorial Board Member Commentary

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center

Comments

Scientists Identify Unique Genomic Features in Testicular Cancer

quotesThese findings are an example of the power of genomic sequencing and bioinformatic analysis - with a…quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School Rutgers-CINJ Associate Director, Clinical Research Director Clinical Oncology Research, RWJ-B Health System

Comments

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer

quotesGreat work by Mike Overman and colleagues showing prolonged benefit to Nivo (3 mg,kg) and Ipi (1 mg,…quotes

member-photo

Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signature Program Laurence S. and Jean J. DeLynn Chair of Oncology

Comments

Study Examines 'Watch-And-Wait' Approach for People with Rectal Cancer

quotesThis is a very interesting study that opens the door to prospective investigation of a randomized tr…quotes

member-photo

Ted Okon

Executive Director Community Oncology Alliance

Comments

Hospitals Sue HHS to Stop Cuts to Medicare Drug Payment Program

quotesThis injunction filed by 3 hospital organizations and 3 hospitals will be interesting to watch. Reg…quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

Congressional Advisory Group Supports Changes In Medicare Doctor Payments

quotesThere are a few of us out there who will remember the famous Abbott and Costello routine that in con…quotes

member-photo

H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA; CEO, Global Resource for Advancing Cancer Education (GRACE)

Comments

Merck's KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer (KEYNOTE-189)

quotesThis is a very important result, in keeping with the results of the phase II KEYNOTE-021g trial that…quotes

member-photo

Winston Wong, PharmD

President, W-Squared Group

Comments

Health Plans Must Not Discriminate Against Patients with Cancer, ASCO States in Letter to CMS

quotesPrior to the "Benefit Exchange" individual market, most states had regulations stating minimal, but …quotes

member-photo

Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst

Comments

U.S. Food and Drug Administration Approves POMALYST® (pomalidomide) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

quotesI am excited to be joining the editorial board on OBR; I have been a fan of the publication since it…quotes

member-photo

Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One

No comments to show!

member-photo

Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology Department of Medicine,Cedars-Sinai Medical Center Associate Director for Academic Program Development Samuel Oschin Comprehensive Cancer Institute Professor of Medicine and Urology, Emeritus David Geffen School of Medicine at UCLA

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology

Comments

German Watchdog Calls For Direct Comparison Of Cancer Immunotherapies

quotesThis call for head to head trials of checkpoint inhibitors is spot on. These trials may be necessar…quotes

member-photo

Jeff Patton, M.D.

CEO Tennessee Oncology

Comments

New Mexico Physician Chosen as AMA President-elect

quotesThis is great news for community oncology. Barbara will be a great champion for us and the value we…quotes

member-photo

Thomas Marsland, MD

Vice President Integrated Community Oncology Network Former Community Representative ASCO Board of Directors

Comments

The Winners and Losers of 340B Changes

quotesIt will be a while to see how this reduction in the 340B compensation for drugs really plays out. …quotes

member-photo

William Harwin MD

Florida Cancer Specialists President and Managing Partner

Comments

Memorial Sloan Kettering to Offer DigniCap® Scalp Cooling Device in New York Metro Area Locations

quotesAt Florida Cancer Specialists we have been using DigniCap for several months at 3 of our site and it…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

First Stereotactic Radiation Therapy System Designed To Treat Early Stage Breast Cancer Receives FDA Clearance

quotesInteresting concept and interesting that it made it thru small business grant all the way to FDA 510…quotes